Corporate Report on Fidelity European Trust Plc – Half‑Year 2026 Results

Financial Performance

Fidelity European Trust Plc (the “Trust”) released its interim financial statement for the six months ending 30 June 2026, reporting a modest rise in the interim dividend and a positive return on its net asset value (NAV). The Trust’s dividend policy, which has historically aimed for a balanced distribution between capital preservation and income generation, was reinforced by the 3.2 % increase in the dividend relative to the same period a year earlier. This increment aligns with the Trust’s strategic objective of sustaining shareholder value while maintaining sufficient reserves for future capital allocation.

The NAV growth, measured at 5.8 % over the reporting period, outperformed the Trust’s own benchmark but still trailed the broader European equity index by approximately 1.7 %. The discrepancy is attributable to a combination of sectoral weighting, timing of equity rebalancing, and the impact of currency fluctuations in the Eurozone and UK markets.

Portfolio Composition and Strategic Focus

The Trust’s asset allocation remains heavily concentrated in European equities, with a particular emphasis on companies positioned to benefit from artificial intelligence (AI) integration and robust, resilient business models. Within the portfolio, key sector exposures include:

  • Pharmaceuticals – The Trust holds a diversified mix of mid‑cap and large‑cap pharmaceutical companies. Notably, the portfolio includes entities engaged in cutting‑edge drug discovery platforms, including antibody‑drug conjugates and small‑molecule inhibitors targeting oncology and rare disease indications. The scientific rationale for these holdings is grounded in the increasing efficacy of precision medicine and the proven therapeutic advantage of targeted molecular pathways.

  • Energy – Exposure to European energy firms is maintained to capture long‑term commodity cycles and the transition to cleaner energy sources. The Trust’s selection criteria focus on companies with strong balance sheets, diversified revenue streams, and active R&D pipelines in renewable technologies and energy storage.

  • Technology – Technology holdings are selectively weighted toward firms developing AI-driven analytics, cloud infrastructure, and cybersecurity solutions. The Trust’s investment thesis in this sector is reinforced by empirical evidence linking AI-enabled automation to productivity gains and competitive differentiation in high‑growth markets.

While the Trust’s performance lagged behind the broader benchmark index, its sectoral allocation is designed to mitigate volatility and generate alpha through exposure to high‑potential, yet comparatively undervalued, opportunities.

Share‑Price Discount Management

A notable feature of the Trust’s management strategy is its ongoing discount‑management program, which includes the repurchase of shares into treasury. By actively buying back shares when the market price falls below the NAV, the Trust seeks to narrow the discount to NAV and enhance shareholder returns. The recent repurchase activity has kept the discount within mid‑single‑digit levels (1.3–1.5 %), a range the board considers optimal for balancing liquidity provision with value maximisation.

Capital Position and Dividend Sustainability

The Trust’s board reiterated its commitment to long‑term capital growth and sustainable dividend practices. Current financial statements indicate that the Trust’s liquidity and capital buffers are robust, with a liquidity coverage ratio comfortably above regulatory requirements and sufficient reserves to support ongoing operations for at least the next twelve months. The board confirmed that the dividend payout ratio remains within the target window of 55–65 % of earnings, ensuring a prudent balance between income generation and reinvestment opportunities.

Swiss Market Context and Lonza Group Performance

Parallel to the Trust’s reporting, the Swiss market experienced a modest decline during the trading session, driven by geopolitical tensions in the Middle East and shifting energy dynamics. Several industrial and financial names recorded modest declines, reflecting heightened market volatility. Lonza Group, a Swiss biopharmaceutical manufacturer with significant exposure to contract manufacturing services and bioprocessing solutions, mirrored this trend with a slight loss in the index.

The volatility in the Swiss market underscores the broader macro‑economic environment in which European asset managers operate. For companies like Lonza, whose business model relies on global supply chain integration and advanced biomanufacturing capabilities, geopolitical uncertainties can impact both operational costs and investor sentiment. The Trust’s exposure to such firms is carefully calibrated against their resilience to macro‑economic shocks and their capacity to leverage technological innovation in manufacturing processes.

Outlook

Fidelity European Trust Plc remains confident in its strategy of disciplined capital allocation and sustainable dividend practices. The board’s affirmation of a stable financial position provides a foundation for continued growth in both capital and income. Looking forward, the Trust will continue to monitor the evolving dynamics of AI integration, pharmaceutical innovation, and energy transition, ensuring that its portfolio remains aligned with sectors that offer robust, scientifically validated growth potential.

End of Report